Head and Neck Squamous Cell Carcinoma

Disease State Hub

Featured

Photoclinic
Photoclinic
03/19/2026
Catherine Anderson-Quinones, BM; Kinza Khan, BA; Sonal Khedkar, BS ; Andrew Wilner, MD; Jay Patel, DPM, MD
The patient was a 48-year-old man who presented with headache, left eye ptosis, a dilated pupil, and tooth pain for 10 days duration. They had a history of hypertension and poorly controlled type 2...
03/19/2026
Slideshow
Slideshow
01/13/2026
Anthony Calabro, MA
Consultant360’s Top 5 Video Interviews of 2025 features compelling discussions on acne management and isotretinoin retrial strategies, esophageal squamous cell carcinoma pathophysiology and knowledge gaps,...
01/13/2026
FDA Alert
FDA Alert
07/21/2025
Kate Young
The FDA announced on June 12 that it has approved pembrolizumab for adult patients with resectable locally advanced head and neck squamous cell carcinoma (HNSCC) whose tumors express PD-L1.
07/21/2025

Interactive Features

Slideshow
Slideshow
01/13/2026
Anthony Calabro, MA
Consultant360’s Top 5 Video Interviews of 2025 features compelling discussions on acne management and isotretinoin retrial strategies, esophageal squamous cell carcinoma pathophysiology and knowledge gaps,...
01/13/2026
Pop Quiz
Pop Quiz
06/04/2025
Anthony Calabro, MA
Esophageal squamous cell carcinoma (ESCC) and adenocarcinoma differ not only in their histology but also in risk factors and anatomical distribution. Test your understanding of where ESCC typically...
06/04/2025

Clinical Insights

Video
Video
07/08/2025
Karyn Goodman, MD, MS
In this video, Karyn A. Goodman, MD, MS, Professor and Vice Chair for Research and Quality in the Department of Radiation Oncology at the Icahn School of Medicine at Mount Sinai, provided insights into...
07/08/2025